ENGLAND'S National Health Service has expanded the influenza vaccines which can be used to immunise patients aged over 65 in the 2019/20 flu season.
Currently the only authorised vaccine for English seniors is Fluad, the adjuvanted trivalent vaccine made by Seqirus, but next year this will be complemented by a cell-grown quadrivalent vaccine and a high-dose trivalent vaccine.
The additional options are expected to become licensed from next month.
It's understood the expanded range follows concerns raised by pharmacies across England about sourcing a sufficient supply of Fluad.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Nov 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Nov 18
